 Connection
Anthony Elias to Carcinoma, Small Cell
This is a "connection" page, showing publications Anthony Elias has written about Carcinoma, Small Cell.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.661 |
|
|
|
-
Sasaki H, Yu CY, Dai M, Tam C, Loda M, Auclair D, Chen LB, Elias A. Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res Treat. 2003 Feb; 77(3):245-52.
Score: 0.204
-
Elias AD, Skarin AT, Richardson P, Ibrahim J, McCauley M, Frei E. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome. Biol Blood Marrow Transplant. 2002; 8(6):326-33.
Score: 0.189
-
Elias A. Hematopoietic stem cell transplantation for small cell lung cancer. Chest. 1999 Dec; 116(6 Suppl):531S-538S.
Score: 0.163
-
Elias A, Ibrahim J, Skarin AT, Wheeler C, McCauley M, Ayash L, Richardson P, Schnipper L, Antman KH, Frei E. Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcome. J Clin Oncol. 1999 Apr; 17(4):1175.
Score: 0.156
-
Elias A. Dose-intensive therapy in small cell lung cancer. Chest. 1998 Jan; 113(1 Suppl):101S-106S.
Score: 0.143
-
Elias AD. Small cell lung cancer: state-of-the-art therapy in 1996. Chest. 1997 Oct; 112(4 Suppl):251S-258S.
Score: 0.141
-
Elias AD. Dose-intensive therapy for small cell lung cancer. Chest. 1995 Jun; 107(6 Suppl):261S-266S.
Score: 0.120
-
Elias AD, Ayash L, Frei E, Skarin AT, Hunt M, Wheeler C, Schwartz G, Mazanet R, Tepler I, Eder JP, et al. Intensive combined modality therapy for limited-stage small-cell lung cancer. J Natl Cancer Inst. 1993 Apr 07; 85(7):559-66.
Score: 0.103
-
Elias AD, Ayash L, Skarin AT, Wheeler C, Schwartz G, Mazanet R, Tepler I, Schnipper L, Frei E, Antman KH. High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancer. Chest. 1993 Apr; 103(4 Suppl):433S-435S.
Score: 0.103
-
Elias AD, Pap SA, Bernal SD. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads. Prog Clin Biol Res. 1990; 333:263-75.
Score: 0.082
-
Elias AD, Cohen BF, Bernal SD. Keratin subtypes of small cell lung cancer. Cancer Res. 1988 May 15; 48(10):2724-9.
Score: 0.073
-
Kraeft SK, Sutherland R, Gravelin L, Hu GH, Ferland LH, Richardson P, Elias A, Chen LB. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system. Clin Cancer Res. 2000 Feb; 6(2):434-42.
Score: 0.041
-
Strauss GM, Lynch TJ, Elias AD, Jacobs C, Herbst R, Leong T, Lynch C, Kwiatkowski DJ, Carey RW, Grossbard ML, Skarin AT. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-73-S12-80.
Score: 0.035
-
Lynch TJ, Lambert JM, Coral F, Shefner J, Wen P, Blattler WA, Collinson AR, Ariniello PD, Braman G, Cook S, Esseltine D, Elias A, Skarin A, Ritz J. Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin. J Clin Oncol. 1997 Feb; 15(2):723-34.
Score: 0.034
-
Elias A. Dose-intensive therapy in lung cancer. Cancer Chemother Pharmacol. 1997; 40 Suppl:S64-9.
Score: 0.033
-
Demetri G, Elias A, Gershenson D, Fossella F, Grecula J, Mittal B, Raschko J, Robertson J. NCCN Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park). 1996 Nov; 10(11 Suppl):179-94.
Score: 0.033
-
Strauss GM, Lynch TJ, Elias AD, Jacobs C, Kwiatkowski DJ, Shulman LN, Carey RW, Grossbard ML, Jauss S, Sugarbaker DJ, et al. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. Semin Oncol. 1995 Aug; 22(4 Suppl 9):70-4.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|